MetLife Q2 EPS $1.94 Beats $1.88 Estimate, Sales $16.62B Miss $16.91B Estimate
Portfolio Pulse from Benzinga Newsdesk
MetLife reported Q2 earnings of $1.94 per share, beating the analyst consensus estimate of $1.88 by 3.19%. However, the company's quarterly sales of $16.62 billion missed the analyst consensus estimate of $16.91 billion by 1.70%. This represents a 3% decrease in earnings and a 9.15% decrease in sales compared to the same period last year.
August 04, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MetLife's Q2 earnings beat estimates but sales missed, indicating mixed performance. Earnings and sales are down compared to last year.
MetLife's earnings beat estimates, which is positive for the stock. However, the miss on sales and the year-over-year decrease in both earnings and sales could negatively impact the stock. The net effect could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100